Adequate initial anticoagulation therapy for DVT is always recommended to prevent the development of thrombosis and pulmonary embolism. Accordingly, intravenous unfractionated heparin, low molecular weight heparin and new generation anticoagulants play a key role in the treatment of acute lower extremity deep vein thrombosis.